COVID-19 Severity Does Not Differ for Patients With Skin Conditions
Acute COVID-19 and its treatment can impact the course of skin disease in vitiligo, psoriasis, atopic dermatitis, chronic urticaria
Two Doses of mRNA-1273 Effective Against SARS-CoV-2 Variants
Vaccine effectiveness against infection with delta variant declines with increasing time since vaccination
Risk Factors Identified for Developing COVID-19
Prospective cohort study conducted in the U.K. shows odds of developing COVID-19 increased with household overcrowding, higher BMI
COVID-19 Breakthrough Infections More Common in Immunocompromised Patients
Immunocompromised patients accounted for 38.2 percent of breakthrough infections
Antibody Response to SARS-CoV-2 Wanes Among Dialysis Patients
Prebreakthrough index RBD values of <10 and 10 to <23 associated with increased odds of breakthrough infection versus value of ≥23
Pfizer Says Final Data Show COVID-19 Pill Stays Strong Against Severe Illness
Latest results show that drug cuts hospitalizations, deaths by nearly 90 percent when taken within three to five days of the start of symptoms
CDC: Only Half of U.S. Nursing Home Residents Have Received Boosters
By the end of October, only about a quarter of fully vaccinated nursing home residents had received a booster
Omicron Resists Pfizer Vaccine but Causes Less Severe Disease
Risk for hospital admission among adults with COVID-19 29 percent lower than in the first pandemic wave that began in March 2020
California Brings Back Indoor Mask Mandate
Order was triggered by a 47 percent spike in the state's per-capita rate of new COVID-19 cases during the past two weeks
mRNA-1273 Has High Vaccine Effectiveness After Five Months
Vaccine effectiveness 87.4 percent against COVID-19 infection, and 95.8 and 97.9 percent against COVID-19 hospitalization, hospital death
